Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending October 25, 2020 Nusinersen provides continued benefits to presymptomatic children with SMA, CBD for LGS: Fewer seizures, but thrombocytopenia risk, Cardiogenic shock rate soars in COVID-positive ACS, COVID-19 experience forced residents to quickly improve patient communication skills, Preventive treatment delays first seizure onset in tuberous sclerosis complex, More must reads Must reads for theWeek ending October 18, 2020 Social factors predicted peripartum depressive symptoms in Black women with HIV, Blood group O linked to decreased risk of SARS-CoV-2 infection, Study: Complications from childhood ALL and its treatment are common, but can be managed, Dual therapy serves as well as triple for most HIV patients, Early hearing impairment interventions key to kindergarten readiness, More must readsMust reads for theWeek ending October 11, 2020 Remdesivir effective, well-tolerated in final trial report, More data on impact of corticosteroids on COVID-19 mortality in patients with COPD, Alcohol problems linked to legal performance-enhancement products, New lupus classification criteria perform well in children, young adults, Teen affective disorders raise risk for midlife acute MI, More must readsMust reads for theWeek ending October 4, 2020 Orthopedic problems in children can be the first indication of acute lymphoblastic leukemia, More must readsMust reads for theWeek ending September 27, 2020 Suicidality jumped in Israel during spring COVID-19 lockdown, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 last »
